Pharmamel Drug Discovery Alternatives & Competitors
12 companies similar to Pharmamel Drug Discovery — Development of new drugs for inflammatory diseases by putting melatonin at the s...
Companies similar to Pharmamel Drug Discovery
Laminar Pharma
Biopharmaceutical company performing discovery, rational design and initial clinical devel...
Intract Pharma
Transforming Patient Care by Replacing Injections with Safer, More Effective Therapeutics...
Skye Bioscience Inc.
Unlocking new therapeutic pathways for metabolic health
Merck & Co., Inc.
Merck develops and produces medicines, vaccines, biologic therapies and animal health prod...
Rival Readout
Competing with Pharmamel Drug Discovery? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
CV6 Therapeutics, (NI) Ltd.
CV6 Therapeutics is dedicated to improving patients lives through the development of novel...
Biodexa Pharmaceuticals PLC
Advancing Medicines for a Brighter Future
Emalex Biosciences
Improving people's lives impacted by central nervous system disorders through meaningful s...
LIPUM AB
We have developed a biological drug SOL-116 for treatment of chronic inflammatory diseases
Celadon Pharmaceuticals
UK-based pharmaceutical company focused on R&D, cultivation, production and sale of cannab...
KeifeRx
KeifeRx is a biopharmaceutical company finding disease-modifying treatments for neurodegen...
Emmaus Life Sciences, Inc
Improving the lives of people with rare disease.
Upstream Bio
Developing treatments for inflammatory diseases
About Pharmamel Drug Discovery
Pharmamel Drug Discovery, headquartered in Spain, is a promising R&D biotech spin-off from the University of Granada formed in 2014. The company's mission is encapsulated in its slogan: "Development of new drugs for inflammatory diseases by putting melatonin at the service of biotechnology." Pharmamel's lead product fo...
Development of innovative drugs, Research and development in biotechnological applications, Patenting and licensing of therapeutic solutions, Clinical trials for new treatments
Healthcare providers, Hospitals, Pharmaceutical companies, Research institutions, Investors in biotech sector
Inflammatory Diseases, Drug Development, Melatonin-based Therapies, Sepsis Treatment, Intravenous Injectable, Clinical Trials, R&D&I, Health Technology, University Spin-Off, Technology Licensing, Pharmaceutical Innovation
B2B, B2D, B2B2B
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Pharmamel Drug Discovery: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Pharmamel Drug Discovery on 5 Mar 2026. The 12 companies listed here were last checked between 11 Mar 2026 and 2 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.